Zoetis Inc (NYSE:ZTS)

85.30
Delayed Data
As of Apr 23
 -0.15 / -0.18%
Today’s Change
54.59
Today|||52-Week Range
86.38
+18.41%
Year-to-Date
ZTS Regular Dividend: ZTS began trading ex-dividend on 04/19/18. A $0.126 dividend will be paid to shareholders of record as of 04/20/18.
KEELEY All Cap Value Fund Comments on Zoetis
Apr 23 / GuruFocus News - Paid Partner Content
Milestone Resources Group Ltd Buys Zoetis Inc, Sells Aetna Inc, Altria Group Inc, Mas...
Apr 18 / GuruFocus News - Paid Partner Content
KEELEY All Cap Value Fund 1st Quarter Shareholder Letter
Apr 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close85.45
Today’s open85.59
Day’s range85.01 - 85.76
Volume1,396,228
Average volume (3 months)2,535,317
Market cap$41.0B
Data as of 4:02pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+6.06%
Earnings growth (this year)+26.68%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+8.57%
P/E ratio48.7
Price/Sales6.69
Price/Book23.21

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.05+0.05%
BAXBaxter International...+0.13+0.19%
INCYIncyte Corp-0.29-0.42%
VRTXVertex Pharmaceutica...+0.54+0.34%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$5.3B
Annual profit (last year)$864.0M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts